declares consultancy roles for Abbvie, Accutar Biotech, Allorion Therapeutics, AstraZeneca, Bayer, Biocartis, Boehringer Ingelheim, Chugai Pharmaceuticals, Daiichi Sankyo, DualityBio, Eisai, Eli Lilly, Frontier Medicines, Hongyun Biotechnology, Merus, Mirati Therapeutics, Monte Rosa, Novartis, Nuvalent, Pfizer, Roche/Genentech, Sanofi, Scorpion Therapeutics, SFJ Pharmaceuticals, Silicon Therapeutics, Syndax, Takeda Oncology, Transcenta and Voronoi
This review highlights the current status of CPP-driven intranasal delivery of peptide drugs and its potential applicability as a universal vehicle in the nasal drug delivery
Dekker, and R
More recent investigations evidenced how women working whole NS exhibit suppressed estradiol levels compared to DS workers, coinciding with disrupted sleep and melatonin rhythms, while half-NS did not significantly affect estradiol synthesis 259
However, a recent study demonstrated that the gold-based drug auranofin, a TRXR inhibitor, also inhibits SARS-CoV-2 replication [79, 83]